Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Cash flows from operating activities:
Net income	$ 3,952	$ 3,837
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	332	316
Gain on sale of assets	0	(395)
Equity compensation expense from awards issued	635	496
Deferred income tax expense	49	51
Change in operating right of use assets	234	235
Changes in operating assets and liabilities:
Accounts receivable	(2,802)	(8,035)
Prepaid expenses and other current assets	120	960
Net of transit accounts receivable and payable	(219)	1,472
Accounts payable and accrued expenses	1,345	(1,667)
Accrued payroll and related costs	976	2,404
Right of use liabilities	(304)	(348)
Income taxes payable	(451)	(141)
Deferred revenue	1,633	(310)
Deposits	24	11
Total adjustments and changes in operating assets and liabilities	2,474	(4,669)
Net cash provided by (used in) operating activities	6,426	(832)
Cash flows from investing activities:
Property and equipment acquired	(669)	(332)
Net cash used in investing activities	(669)	(332)
Cash flows from financing activities:
Borrowings under line of credit	34,738	32,807
Repayments under line of credit	(43,383)	(22,438)
Issuance of stock for employee stock purchase plan	364	347
Retirement of common shares	(1,317)	0
Changes in finance lease obligations	(116)	(116)
Common stock repurchase	0	(8,184)
Net cash (used in) provided by financing activities	(9,714)	2,416
Effect of exchange rate changes on cash and cash equivalents	(228)	234
(Decrease) increase in cash and cash equivalents	(4,185)	1,486
Cash and cash equivalents at beginning of period	6,284	339
Cash and cash equivalents at end of period	2,099	1,825
Supplemental cash flow information:
Interest	473	187
Income taxes	541	131
Non-cash financing activities:
Right of use assets obtained in exchange for lease obligations	$ 602	$ 0